Research

Approximately one in every five adults1 has sleep-disordered breathing (SDB).

An expanding body of scientific evidence clearly indicates that SDB has a profound negative impact on public health.

Through its strong partnership with the global medical community, ResMed is committed to:

  • Increasing awareness of the dangers of untreated SDB
  • Supporting ongoing research into the correlation of SDB with other health risks
  • Finding effective clinical solutions to improve the health and lives of SDB patients

At ResMed, we are focused on developing our industry and patient expertise in sleep and respiratory disorders. That’s why we continue to research areas related to sleep-disordered breathing.

Sleep

ResMed is a global pioneer and leader in sleep and respiratory disorders. All about our research on sleep-disordered breathing and related innovation and technology.

Sleep disordered breathing and mandibular repositioning devices

There’s a growing body of clinical research that demonstrates the efficacy and compliance of mandibular repositioning devices (MRDs) in treating osbstructive sleep apnoea and snoring. The following clinical research papers demonstrate results in particular for ResMed’s Narval CC™ MRD.

Cardiology

ResMed is committed to researching the association between sleep apnoea and cardiovascular issues. All about our research on sleep and cardiology, specifically on heart failure and CSA-CSR.

Respiratory care

At ResMed, we provide a number of solutions to treat respiratory disorders. Noninvasive ventilation (NIV) can used to treat patients with respiratory dysfunction. All about respiratory care and NIV.

iVAPS algorithms

At ResMed, we’re focused on improving patient compliance. That’s why we continue to develop ventilators around iVAPS algorithms, an innovative technology that adapts to patients.

Farrell historical landmarks

ResMed Founder and Chairman Dr. Peter Farrell identifies key research findings that are shaping the field of sleep medicine today.

ResMed is dedicated to innovating and changing lives. We support and actively engage in research initiatives in five associated areas of clinical focus related to sleep-disordered breathing.

Diabetes research at ResMed

ResMed is dedicated to innovating and changing lives. We support and actively engage in research initiatives related to type 2 diabetes.

Cardiology research at ResMed

ResMed is dedicated to innovating and changing lives. We support and actively engage in research initiatives related to cardiology.

Chronic Obstructive Pulmonary Disease (overlap syndrome)

Obstructive Sleep Apnoea (OSA) and chronic obstructive pulmonary disease (COPD) often coexist within a patient. Learn more about overlap syndrome on our research initiative page.

Occupational health and safety research at ResMed

ResMed is dedicated to innovating and changing lives. We support and actively engage in research initiatives related to occupational health and safety.

Peri-operative care research at ResMed

ResMed is dedicated to innovating and changing lives. We support and actively engage in research initiatives related to peri-operative care.

Other research at ResMed

ResMed is dedicated to innovating and changing lives. We support and actively engage in research initiatives related to sleep-disordered breathing.

Clinical results for Narval CC™ – the ORCADES study

The 5-year multicentre ORCADES study demonstrated both the efficacy and compliance of the Narval CC™ MRD.